000 01518 a2200409 4500
005 20250516204501.0
264 0 _c20140520
008 201405s 0 0 eng d
022 _a1552-5783
024 7 _a10.1167/iovs.13-13599
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReijerkerk, Arie
245 0 0 _aSystemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation.
_h[electronic resource]
260 _bInvestigative ophthalmology & visual science
_cApr 2014
300 _a2788-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAutoimmune Diseases
_xdrug therapy
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Combinations
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aGlutathione
_xadministration & dosage
650 0 4 _aImmunohistochemistry
650 0 4 _aLiposomes
650 0 4 _aMale
650 0 4 _aMethylprednisolone
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aRats, Inbred Lew
650 0 4 _aTreatment Outcome
650 0 4 _aUveitis
_xdrug therapy
700 1 _aAppeldoorn, Chantal C M
700 1 _aRip, Jaap
700 1 _ade Boer, Marco
700 1 _aGaillard, Pieter J
773 0 _tInvestigative ophthalmology & visual science
_gvol. 55
_gno. 4
_gp. 2788-94
856 4 0 _uhttps://doi.org/10.1167/iovs.13-13599
_zAvailable from publisher's website
999 _c23698761
_d23698761